MSCI, Inc.
MSCIMSCI, Inc. is a leading provider of investment decision support tools, including indexes, analytics, and data solutions. The company is known for its comprehensive global equity, fixed income, and real estate indexes, which are widely used by asset managers, pension funds, and other institutional investors for benchmarking and portfolio analysis. MSCI's offerings help investors manage risk, optimize portfolios, and adhere to regulatory requirements across international markets.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| November 28, 2025 | $1.80 | 2025-11-14 | 2025-11-14 |
| August 29, 2025 | $1.80 | 2025-08-15 | 2025-08-15 |
| May 30, 2025 | $1.80 | 2025-05-16 | 2025-05-16 |
| February 28, 2025 | $1.80 | 2025-02-14 | 2025-02-14 |
| November 29, 2024 | $1.60 | 2024-11-15 | 2024-11-15 |
Dividends Summary
- Consistent Payer: MSCI, Inc. has rewarded shareholders with 45 dividend payments over the past 11 years.
- Total Returned Value: Investors who held MSCI shares during this period received a total of $38.00 per share in dividend income.
- Latest Payout: The most recent dividend of $1.80/share was paid 56 days ago, on November 28, 2025.
- Yield & Schedule: MSCI currently pays dividends quarterly with an annual yield of 1.22%.
- Dividend Growth: Since 2014, the dividend payout has grown by 900.0%, from $0.18 to $1.80.
- Dividend Reliability: MSCI has maintained or increased its dividend for 45 consecutive payments.
Company News
The article examines conspiracy theories that Morgan Stanley and MSCI orchestrated Bitcoin's Q4 2025 crash to accumulate coins cheaply before launching ETFs. It debunks four main myths by analyzing market mechanics, leverage, macroeconomic factors, and regulatory developments, concluding that while TradFi's crypto embrace creates imbalances favor...
MSCI reported Q2 2025 financial results with revenue of $772.7 million, exceeding expectations. While core segments showed stable growth, the company experienced slower new business, particularly in sustainability and climate products.
Resmed, a global leader in health technology, has appointed Salli Schwartz as its new Chief Investor Relations Officer. Schwartz brings extensive experience from her previous roles at Illumina, MSCI, and Moody's, and will lead Resmed's global investor relations function.
BofA analysts expect mostly in-line or better Q1 earnings for industrial companies, with Q3 flagged as a potential earnings trough. They highlight 3M, Johnson Controls, and GE Vernova as top picks, despite lowering EPS estimates due to tariff uncertainty.
MSCI, a leader in investment decision support tools, reported mixed Q4 earnings. While adjusted EPS beat expectations, revenue fell slightly short. The company saw solid earnings amidst lower net income, driven by the absence of previous period gains. MSCI remains focused on expanding its Index and ESG offerings, though it faces some operational ...
